We are live on ! Find out more
AST.WS

Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS

Delisted

AST.WS was delisted on the 26th of September, 2017.

Back to rankings

38 hedge funds and large institutions have $142K invested in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in 2016 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+38
Holders Change %
–
% of All Funds
1.01%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
38
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BC
Broadwood Capital
New York
+$171K
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$95.3K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$46.8K
4
BCM
Bridgeway Capital Management
Texas
+$15.4K
5
Goldman Sachs
Goldman Sachs
New York
+$9.65K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadwood Capital
New York
$70K +$171K +328,205 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$37K +$95.3K +182,991 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$18K +$46.8K +89,777 New
BCM
4
Bridgeway Capital Management
Texas
$6K +$15.4K +29,610 New
Goldman Sachs
5
Goldman Sachs
New York
$4K +$9.65K +18,533 New
Northern Trust
6
Northern Trust
Illinois
$3K +$9.14K +17,548 New
BIT
7
BlackRock Institutional Trust
California
$1K +$1.49K +2,856 New
TA
8
Teachers Advisors
New York
$1K +$1.52K +2,925 New
California State Teachers Retirement System (CalSTRS)
9
California State Teachers Retirement System (CalSTRS)
California
$1K +$2.3K +4,423 New
Morgan Stanley
10
Morgan Stanley
New York
$1K +$3.07K +5,898 New
AIG
11
American International Group
New York
$245 +$637 +1,223 New
WP
12
WealthPLAN Partners
Nebraska
$3 +$14 +26 New
CFA
13
CT Financial Advisors
Pennsylvania
$1 +$2 +4 New
AA
14
Apriem Advisors
California
– +$1 +2 New
AssetMark Inc
15
AssetMark Inc
California
– +$1 +2 New
CPIG
16
Chicago Partners Investment Group
Illinois
– +$2 +3 New
SIG
17
Stanford Investment Group
California
– +$2 +4 New
MFS
18
MSI Financial Services
Massachusetts
– +$3 +6 New
CTC
19
Central Trust Company
Missouri
– +$4 +8 New
PNC Financial Services Group
20
PNC Financial Services Group
Pennsylvania
– +$4 +8 New
VCM
21
Versant Capital Management
Arizona
– +$5 +10 New
CG
22
Cutler Group
California
– +$8 +16 New
AG
23
Advisor Group
Arizona
– +$11 +21 New
First Manhattan
24
First Manhattan
New York
– +$14 +26 New
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
– +$18 +34 New
1
2

AST.WS Hedge Fund Activity: Q2 2016 in Review

38 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) for Q2 2016, worth a combined $142K.

Buyers outnumbered sellers: 38 funds opened new AST.WS positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Broadwood Capital, opening a new position worth an estimated $171K.

  • 38 institutional investors held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) as of Q2 2016, up from 0 in Q1 2016.
  • Funds reported $142K of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) stock for Q2 2016.
  • 38 funds opened new Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) positions in Q2 2016 and 0 closed out, a net change of +38 holders.
  • The largest Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) buyer in Q2 2016 was Broadwood Capital, an estimated $171K added.

Based on aggregated 13F filings for Q2 2016.